Urgent Information Regarding the Recall of Medicines from the Department of Drug Administration
Department of Drug Administration Drug Recall Notice | Published: 09/16/2077
While testing the samples of medicines collected during market monitoring from Department of Drug Administration, batch of details produced by the manufacturer as per the details numbers. As the medicine was found to be of low quality the medicine. This information has been published for the information of the authorized importers and their representatives of the concerned industry and related industry to stop the sale and distribution as per Section 14 of the Drugs Act 2035 and to recall it immediately from the market and submit the details thereof to this department. Also, all concerned are requested not to recommend, sell, distribute and even use the drug.
Name of Medicine Department of Drug Administration Recall
- MLT 10 (Montelukast Tablet IP) manufactured by Curex Pharmaceuticals
- Proton-P (Pantoprazole Sodium Delayed Release Tablet USP 40mg) manufactured by Reliance Formulation Pvt. Ltd
Discussion about this post